Reilly Thomas Charles
SEC CIK 1827590 · EDGAR
BoughtSold
Most active insiders at AMRN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Keenan David Paul | EVP, COO | — | — |
| 2 | Fishman Peter L. | SVP, CFO | — | — |
| 3 | Provoost Jonathan | EVP, CLO | — | — |
| 4 | O'Connor Oliver | Dir | — | — |
| 5 | Cohen Paul | Dir | — | — |
| 6 | Sullivan Diane E. | Dir | — | — |
| 7 | Sterling Louis III | Dir | — | — |
| 8 | Bonfiglio Patrice Eadon | Dir | — | — |
| 9 | Berg Aaron | Pres, CEO | — | — |
| 10 | Horn Keith | Dir | — | — |
Reilly Thomas Charles made no open-market trades at AMRN in the last 12 months.
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-01 | 2024-07-01 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | F - Tax | $0.69 | -8,209 | 94.3K | -8% | -$5,664 |
| D | 2024-07-01 | 2024-07-01 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | M - OptEx | — | +16.7K | 102.5K | +19% | — |
| D | 2024-06-21 | 2024-06-20 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | F - Tax | $0.73 | -16.4K | 85.8K | -16% | -$12.0K |
| D | 2024-06-21 | 2024-06-20 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | M - OptEx | — | +33.3K | 102.3K | +48% | — |
| D | 2024-02-02 | 2024-01-31 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | F - Tax | $1.24 | -24.6K | 68.9K | -26% | -$30.4K |
| D | 2024-02-02 | 2024-01-31 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | M - OptEx | — | +44.9K | 93.5K | +93% | — |
| D | 2024-01-12 | 2024-01-10 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | M - OptEx | — | +51.5K | 76.9K | +203% | — |
| D | 2024-01-12 | 2024-01-10 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | EVP, CFO | F - Tax | $0.97 | -28.3K | 48.5K | -37% | -$27.5K |
| D | 2023-07-05 | 2023-07-01 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | SVP, CFO | M - OptEx | — | +16.7K | 33.6K | +99% | — |
| D | 2023-07-05 | 2023-07-01 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | SVP, CFO | F - Tax | $1.19 | -8,209 | 25.4K | -24% | -$9,769 |
| D | 2023-06-22 | 2023-06-20 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | SVP, CFO | F - Tax | $1.19 | -16.4K | 16.9K | -49% | -$19.5K |
| D | 2023-06-22 | 2023-06-20 | AMRN | AMARIN CORP PLC\UK | Reilly Thomas Charles | SVP, CFO | M - OptEx | — | +33.3K | 33.3K | New | — |
| 2022-03-04 | 2022-03-03 | TVRD | Tvardi Therapeutics, Inc. | Reilly Thomas Charles | CFO | S - Sale | $11.38 | -2,044 | 37.8K | -5% | -$23.3K | |
| DM | 2022-03-01 | 2022-02-25+ | TVRD | Tvardi Therapeutics, Inc. | Reilly Thomas Charles | CFO | A - Grant | $2.17 | +25.3K | 34.5K | +276% | +$54.9K |
| 2021-12-21 | 2021-12-17 | TVRD | Tvardi Therapeutics, Inc. | Reilly Thomas Charles | CFO | A - Grant | $0.00 | +11.2K | 14.5K | +333% | $0 | |
| 2021-09-01 | 2021-08-30 | TVRD | Tvardi Therapeutics, Inc. | Reilly Thomas Charles | CFO | S - Sale | $14.20 | -1,982 | 3,352 | -37% | -$28.1K | |
| 2021-08-26 | 2021-08-24 | TVRD | Tvardi Therapeutics, Inc. | Reilly Thomas Charles | CFO | A - Grant | $0.00 | +5,334 | 5,334 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations